Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Medtronic
AstraZeneca
Express Scripts
McKinsey

Last Updated: October 2, 2022

Investigational Drug Information for Mitoglitazone


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Mitoglitazone?

Mitoglitazone is an investigational drug.

There have been 3 clinical trials for Mitoglitazone. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2008.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Alzheimer Disease. The leading clinical trial sponsors are Metabolic Solutions Development Company and [disabled in preview].

Recent Clinical Trials for Mitoglitazone
TitleSponsorPhase
3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's DiseaseMetabolic Solutions Development CompanyPhase 2
Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic PatientsMetabolic Solutions Development CompanyPhase 2
A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active ComparatorMetabolic Solutions Development CompanyPhase 2

See all Mitoglitazone clinical trials

Clinical Trial Summary for Mitoglitazone

Top disease conditions for Mitoglitazone
Top clinical trial sponsors for Mitoglitazone

See all Mitoglitazone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Medtronic
AstraZeneca
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.